The United States has reported a significant rise in influenza cases during December 2023, following what the Centers for Disease Control and Prevention (CDC) describes as the most severe flu season since 2018. This alarming increase comes on the heels of a particularly tough year for flu-related illnesses, raising concerns about the potential implications for public health.
According to the CDC, over 3,100 people died from influenza in the year ending August 2025. As of December 20, 2023, the nation had recorded approximately 7.5 million influenza cases and 81,000 hospitalizations. The number of cases saw a striking 25% increase compared to the previous week, with 32 states reporting “high or very high” levels of flu activity.
Jennifer Nuzzo, an epidemiologist at Brown University, emphasized the importance of vaccination. “The bottom line for people is that if they haven’t gotten vaccinated against the flu, they should get vaccinated, particularly young children and older adults,” Nuzzo stated. This advice comes in light of the substantial health risks associated with the current flu season, which has already resulted in 279 pediatric deaths, the highest number recorded during a seasonal influenza epidemic.
Concerns About Flu Vaccine Uptake
The surge in flu cases is compounded by concerns regarding vaccination rates. The CDC reported that approximately 130 million flu vaccines had been distributed by early December, which is 13 million fewer than the same timeframe last year. Nuzzo criticized the cancellation of a campaign led by Health Secretary Robert F. Kennedy Jr. that aimed to encourage vaccination, calling it “incredulous” given the severity of the previous season.
Epidemiologists fear that the reduction in vaccination efforts may lead to even greater challenges this flu season. “A lot of people are getting the flu at the same time, which is always tough,” Nuzzo explained. “It could be a worse season, in part because more people will need care than hospitals can easily deliver.”
Additionally, a new variant of the influenza virus, known as subclade K, has emerged, contributing to the elevated flu activity. The flu season has also started earlier than usual in Europe, where high or very high influenza activity was recorded in December.
Public Awareness and Testing Options
Nuzzo also highlighted the need for public awareness regarding at-home testing options for influenza. Many individuals may not realize they can obtain a test from local pharmacies. “There are some people who might benefit from medication if they tested positive, but that medication needs to be given very soon after symptoms start,” she noted.
Concerns persist about the efficacy of the new round of vaccine shots against the emerging variant. Nuzzo stated, “We have some reason to think that the protection may be lower, but it’s likely still going to give you some important protection.”
As the flu season progresses, public health officials continue to monitor trends and encourage vaccination to mitigate the impact of the virus. With the potential for increased hospitalizations and severe illness, the focus remains on promoting awareness and ensuring access to medical care and vaccination for vulnerable populations.
